Profile
AXDX ABT BSX-PA BSX SYK MDT
Company Name Accelerate Diagnostics, Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $14.56M $223.47B $175.45B $150.72B $129.62B $107.94B
Employees 0.11K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Mr. Jack Phillips Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Geoffrey Straub Martha
Ratings
AXDX ABT BSX-PA BSX SYK MDT
Quant Rating Score 2 4 1 3 3
Quant Rating Sell Buy Strong Sell Neutral Neutral
Trading
AXDX ABT BSX-PA BSX SYK MDT
Last Close $0.5775 $128.85 $122.18 $101.9 $365.06 $84.16
High 52 $2.02 $140.22 $122.18 $106.18 $399.9 $94.5
Low 52 $0.53 $100.07 $122.18 $71.87 $315.94 $76.84
Price vs. 52 Week High -71.41 % -8.11 % 0 % -4.03 % -8.71 % -10.94 %
Price vs. 52 Week Low 8.96 % 28.76 % 0 % 41.78 % 15.55 % 9.53 %
Total Return
AXDX ABT BSX-PA BSX SYK MDT
1 Month Return -34.16 % 1.77 % 0 % -0.43 % -0.74 % -4.61 %
3 Month Return -50.64 % 3.06 % 0 % -0.04 % -7.42 % -6.69 %
6 Month Return -69.28 % 12.81 % 0 % 20.26 % 3.47 % -7.1 %
9 Month Return -55.58 % 22.43 % 0 % 36.01 % 10.07 % 6.94 %
YTD Return -51.88 % 13.92 % 0 % 14.08 % 1.39 % 5.36 %
1 Year Return -37.91 % 19.83 % 0 % 39.26 % 8.78 % 5.54 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AXDX ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.77 % - - 0.97 % 3.33 %
Dividend Paid and Capex Coverage Ration (TTM) -47.53 % 1.42 % 3.37 % 3.37 % 2.15 % 1.34 %
Dividend Per Share (TTM) - 2.28 % - - 3.28 % 2.8 %
Payout Ratio (TTM) - 28.62 % 1.24 % 1.13 % 40.73 % 84.62 %
Growth
AXDX ABT BSX-PA BSX SYK MDT
Asset Growth -8.96 % 11.2 % 12.12 % 7.66 % -1.06 %
Gross Profit Growth 6.04 % 5.01 % 16.12 % 10.25 % 3.12 %
Revenue Growth -2.99 % 4.59 % 17.61 % 10.23 % 3.64 %
Revenue 3 Year -73.7 % -0.18 % 36.16 % 30.69 % 8.85 %
Revenue 5 Year -70.57 % 34.24 % 47.52 % 49.02 % 7.41 %
Revenue 10 Year 1695.16 % 80.43 % 104.22 % 132.01 % 43.65 %
EBIT Growth 34.64 % 5.36 % 11.1 % -5.12 % -6.22 %
Net Income Growth 18.78 % 134.18 % 16.32 % -5.43 % -2.18 %
Net Income 3 Yeari Growth Per Share 82.94 % 94.27 % 72.05 % 48.52 % 3.26 %
Net Income 5 Yeari Growth Per Share 86.11 % 271.11 % -62.72 % 41.05 % -19.5 %
Net Income 10 Yeari Growth Per Share 69.71 % 410.99 % 524.58 % 477.35 % -9.48 %
Operating Income Growth 34.64 % 5.36 % 11.1 % -5.12 % -6.22 %
Operating Cash Flow Growth (CFG) 39.81 % 17.86 % 37.24 % 14.31 % 12.39 %
Operating 3 Year CFG 86.46 % -16.72 % 77.55 % 28.64 % 10.18 %
Operating 5 Year CFG 91.27 % 42.4 % 76.92 % 90.05 % -1.78 %
Operating 10 Year CFG 75.89 % 102.79 % 143.61 % 136.49 % 3.3 %
EPS Growth 56.48 % 134.55 % 16.67 % -5.76 % -2.12 %
EPS Diluted Growth 56.48 % 134.56 % 16.82 % -5.94 % -2.13 %
Book Value Per Share -50.88 % 23.54 % 11.25 % 10.57 % -2.26 %
Share Holder 3 Year Equity Growth Per Share 57.67 % 36.46 % 26.58 % 37.24 % -1.1 %
Share Holder 5 Year Equity Growth Per Share -77.64 % 56.53 % 48.35 % 58.15 % 1.66 %
Share Holder 10 Year Equity Growth Per Share -115.9 % 92.83 % 186.31 % 138.47 % 94.93 %
Dividend Per Share Growth - 8.02 % -100 % 6.63 % 1.54 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % 26.97 % 19.02 %
Dividend 5 Year Growth Per Share - 72.53 % - 53.81 % 38.05 %
Dividend 10 Year Growth Per Share - 148.92 % - 162.12 % 147.94 %
Debt Growth 61.53 % -5.37 % 13.21 % -89.16 % 6.91 %
Free Cash Flow Growth 41.32 % 25.54 % 55.31 % 11.19 % 13.54 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 26 Apr 2024
Profitability
AXDX ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 23.12 % 55.59 % 67.02 % 67.15 % 62.84 % 62.89 %
Return on Assets TTM -175.26 % 16.46 % 4.7 % 5.16 % 6.97 % 4.73 %
Return on Equity TTM 121.19 % 32.37 % 8.94 % 9.82 % 15.02 % 8.69 %
Return on Capital Employed TTM 1334.97 % 10.32 % 8.63 % 9.32 % 10.75 % 7.74 %
Net Income Per EBT TTM 99.87 % 191.1 % 81.07 % 81.97 % 85.71 % 81.56 %
EBT Per Ebit TTM 141.92 % 101.01 % 80.13 % 80.59 % 91.89 % 86.39 %
EBIT Per Revenue TTM -301.85 % 16.55 % 17.01 % 17.52 % 16.82 % 18.21 %
Cash Flow To Debt Ratio TTM -38.19 % 56.97 % 30.82 % 30.82 % 31.2 % 27.41 %
Receivables Turnover TTM 5.74 4.42 6.55 6.86 5.67 5.43
Payables Turnover TTM 1.86 4.44 5.75 6.01 5 5.39
Inventory Turnover TTM 3.15 3.01 1.97 2.05 1.76 2.2
Fixed Asset Turnover TTM 201.07 % 393.6 % 447.28 % 468.83 % 655.31 % 503.55 %
Asset Turnover TTM 40.97 % 51.53 % 42.51 % 44.56 % 52.58 % 36.9 %
Operating Cash Flow Per Share TTM -1.04 4.94 2.33 2.33 11.13 5.69
Free Cash Flow Per Share TTM -1.06 3.67 1.66 1.65 9.15 4.26
Cash Per Share TTM 69.94 % 460.07 % 28.12 % 28.03 % 1155.38 % 617.75 %
Operating Cash Flow Sales Ratio TTM -206.82 % 20.4 % 20.51 % 19.57 % 18.77 % 21.97 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.1 % 74.21 % 70.98 % 70.98 % 82.2 % 74.96 %
Cash Flow Coverage Ratios TTM -38.19 % 56.97 % 30.82 % 30.82 % 31.2 % 27.41 %
Price To Free Cash Flows Ratio TTM -0.59 35.19 57.79 61.82 37.17 19.74
Price To Operating Cash Flows Ratio TTM -0.56 26.07 40.82 43.82 30.5 14.8
Price Cash Flow Ratio TTM -0.56 26.07 40.82 43.82 30.5 14.8
Income Statement (TTM)
AXDX ABT BSX-PA BSX SYK MDT
Revenue $0.01B $41.95B $16.75B $16.75B $22.6B $32.36B
Gross Profit $0B $23.24B $11.49B $11.49B $14.44B $21.15B
Gross Profit Ratio 23.12% 55.41% 68.61% 68.61% 63.91% 65.34%
EBITDA $-0.03B $10.83B $2.6B $2.6B $5.72B $8.2B
Net Income $-0.05B $13.4B $1.85B $1.85B $2.99B $3.68B
EPS Diluted -2.15 7.64 1.25 1.25 7.76 2.76
Balance Sheet (MRQ)
AXDX ABT BSX-PA BSX SYK MDT
Long Term Debt $0.05B $13.52B $8.97B $8.97B $0B $24.77B
Total Liabilities $0.08B $33.51B $17.39B $17.39B $22.34B $39.56B
Total Equity $-0.06B $47.9B $22B $22B $20.63B $50.42B
Total Investments $0B $1.24B $0.56B $0.56B $0.75B $8.34B
Total Debt $0.06B $15.02B $10.75B $10.75B $1.41B $26.05B
Total Assets $0.03B $81.41B $39.4B $39.4B $42.97B $89.98B
Cash Flow Statement (TTM)
AXDX ABT BSX-PA BSX SYK MDT
Net Income $-0.05B $13.4B $1.85B $1.85B $2.99B $3.68B
Inventory $-0B $-0.06B $-0.23B $-0.23B $0.05B $-0.14B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.67B
Operating Cash Flow $-0.02B $8.56B $3.44B $3.44B $4.24B $6.79B
Capital Expenditure $0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 128.85
ADGM Adagio Medical Holdings, Inc. 1.3
AEMD Aethlon Medical, Inc. 0.3813
AFIB Acutus Medical, Inc. 0.041
AHCO AdaptHealth Corp. 8.41
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 183.35
ALUR Allurion Technologies Inc. 2.4
AMIX Autonomix Medical, Inc. Common Stock 2.08
ANIK Anika Therapeutics, Inc. 14.43
AORT Artivion, Inc. 23.84
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 0.8905
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 11.51
AVNS Avanos Medical, Inc. 12.35
AVR Anteris Technologies Global Corp. Common Stock 4.98
AXGN AxoGen, Inc. 16.4
AXNX Axonics, Inc. 70.98
ETFs With Exposure to AXDX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 270.64
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00004 120.13
VXF Vanguard Extended Market Index Fund 0 170
IWC iShares Micro-Cap ETF 0.00849 110.33
VTSAX Vanguard Total Stock Market Index Fund 0 131.81
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 128.99
VITSX Vanguard Total Stock Market Index Fund 0 131.83
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000134208 92.89
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 129
JKK iShares Morningstar Small-Cap Growth ETF 0.01 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
VEMPX Vanguard Extended Market Index InstlPlus 0 318.32
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 247.3
Unlock